These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27441838)

  • 1. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.
    Bengtsson AA; Trygg J; Wuttge DM; Sturfelt G; Theander E; Donten M; Moritz T; Sennbro CJ; Torell F; Lood C; Surowiec I; Rännar S; Lundstedt T
    PLoS One; 2016; 11(7):e0159384. PubMed ID: 27441838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus.
    van der Meulen TA; Harmsen HJM; Vila AV; Kurilshikov A; Liefers SC; Zhernakova A; Fu J; Wijmenga C; Weersma RK; de Leeuw K; Bootsma H; Spijkervet FKL; Vissink A; Kroese FGM
    J Autoimmun; 2019 Feb; 97():77-87. PubMed ID: 30416033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
    McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
    Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
    PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does stress response axis activation differ between patients with autoimmune disease and healthy people?
    Montero-López E; Peralta-Ramírez MI; Ortego-Centeno N; Sabio JM; Callejas-Rubio JL; Navarrete-Navarrete N; García-Ríos MC; Santos-Ruiz A
    Stress Health; 2024 Aug; 40(4):e3392. PubMed ID: 38454759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.
    van der Goes MC; Bossema ER; Hartkamp A; Godaert GL; Jacobs JW; Kruize AA; Derksen RH; Bijlsma JW; Geenen R
    J Rheumatol; 2011 Feb; 38(2):285-8. PubMed ID: 21159832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
    Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
    Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
    Ouyang X; Dai Y; Wen JL; Wang LX
    Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
    van der Kroef M; van den Hoogen LL; Mertens JS; Blokland SLM; Haskett S; Devaprasad A; Carvalheiro T; Chouri E; Vazirpanah N; Cossu M; Wichers CGK; Silva-Cardoso SC; Affandi AJ; Bekker CPJ; Lopes AP; Hillen MR; Bonte-Mineur F; Kok MR; Beretta L; Rossato M; Mingueneau M; van Roon JAG; Radstake TRDJ
    Eur J Immunol; 2020 Jan; 50(1):119-129. PubMed ID: 31424086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
    Tjensvoll AB; Gøransson LG; Harboe E; Kvaløy JT; Omdal R
    Eur J Neurol; 2014 Aug; 21(8):1124-1130. PubMed ID: 24779894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
    Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
    Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
    Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
    Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of interleukin-12 in immune-mediated rheumatic diseases].
    Spadaro A; Scrivo R; Rinaldi T; Riccieri V; Sili Scavalli A; Taccari E; Valesini G
    Reumatismo; 2002; 54(2):113-21. PubMed ID: 12105679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren's syndrome in familial systemic lupus.
    Scofield RH; Bruner GR; Harley JB; Namjou B
    Ann Rheum Dis; 2007 Mar; 66(3):410-3. PubMed ID: 16984944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
    Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
    Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.